Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460005
Status:
COMPLETED
Last Update Posted:
2008-04-15
First Post:
2007-04-12
Brief Title:
Clinical Study Of Migraine Evolution
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Multicenter Study to Determine the Clinical Characteristics of the Temporal Aspects of Migraine in a Canadian Population Clinical Study Of Migraine Evolution C-SOME
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Understanding the speed at which migraine headaches develop is of importance to patients Determining the proportions in which different headache pain build-up occurs may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect high tolerability and long action Conversely medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None